GT Biopharma, Inc. (NASDAQ:GTBP) Short Interest Down 16.8% in October

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 132,900 shares, a decline of 16.8% from the October 15th total of 159,800 shares. Based on an average daily volume of 147,900 shares, […]

Related Keywords

,Atria Wealth Solutions Inc ,Millennium Management ,Gt Biopharma Inc ,Nasdaq ,Get Free Report ,Wealth Solutions ,Street Corp ,Jane Street Group ,Tri Specific Killer Engager ,Gt Biopharma ,Nasdaq Gtbp ,Gtbp ,Medical ,Stocks ,Options ,Put ,Call ,